retatrutide spray Nasal Spray: Mechanism, Benefits, Side Effects Retatrutide Nasal Spray | Reta

When considering current recommendations from the ADA for add-on therapy to metformin in patients not achieving individualized glycemic goals, PIONEER 2 provides valuable data comparing the addition of either an oral GLP-1 receptor agonist or an SGLT-2 inhibitor

Phase 2 dose escalation protocol The Phase 2 trial evaluated multiple dose levels ranging from 0.5mg to 12mg administered once weekly via subcutaneous injection

Consequent to these results, dulaglutide obtained FDA permission for administration in individuals with an eGFR as low as 15 mL/min per 1.73 m2 (Tuttle et al

If you qualify, they can prescribe FDA approved weightloss medications in both pill and injectable options